Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Vortioxetine Orally in Patients With Major Depressive Disorder
Clinical trial NCT02919501 · COMPLETED
Trial details
- NCT number
- NCT02919501
- Sponsor
- H. Lundbeck A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-27
- Primary completion
- 2017-04-27
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.